89 Results

People

  1. Brentjens
    Brentjens
  2. Halton
    Halton
  3. Park
    Park
  4. Riviere
    Riviere
  5. Sadelain
    Sadelain
  6. Diamonte
    Diamonte
  7. Scheinberg
    Scheinberg
  8. Wang
    Wang
  9. Palomba
    Palomba
  10. Maslak
    Maslak

Groups

  1. Adult Leukemia (89)
  2. Center for Hematologic Malignancies (89)
  3. Department of Medicine (89)
  4. GSK Faculty (89)
  5. Hematologic Malignancies Research (89)
  6. Hematologic Malignancies, Division of (89)
  7. Nursing (89)
  8. Sloan Kettering Institute Faculty (70)
  9. Molecular Pharmacology and Chemistry Program Faculty (63)
  10. Advanced Practice Providers (52)
  1. "Hematologic Malignancies Research"
  2. "Nursing"
  3. "Adult Leukemia"
Formats
  1. Meeting Abstract (61)
  2. Journal Article (27)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (89)
  2. Center for Hematologic Malignancies (89)
  3. Department of Medicine (89)
  4. GSK Faculty (89)
  5. Hematologic Malignancies Research (89)
  6. Hematologic Malignancies, Division of (89)

More Groups

People
  1. Renier Brentjens (59)
  2. Elizabeth Halton (48)
  3. Jae Park (48)
  4. Isabelle Riviere (39)
  5. Michel Sadelain (34)
  6. Claudia Diamonte (30)

More People

Years
  1. 2022 (1)
  2. 2021 (5)
  3. 2020 (8)
  4. 2019 (17)
  5. 2018 (10)
  6. 2017 (5)

More Years

Publications
  1. Blood (35)
  2. Journal of Clinical Oncology (16)
  3. Biology of Blood and Marrow Transplantation (5)
  4. Blood Advances (4)
  5. Bone Marrow Transplantation (3)
  6. Leukemia (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. American Society of Clinical Oncology (16)
  3. Nature Publishing Group (11)
  4. Elsevier Inc. (6)
  5. American Association for Cancer Research (5)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save